ALL announcements
Expansion of distribution partnership in Europe
Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership
Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
See More 
Actylis Acquires Pharm-Rx
We are delighted to announce the strategic acquisition of Pharm-Rx. This acquisition significantly enhances our ability to deliver exceptional value to our customers, increase our range of solutions for clients, and strengthen our strategic supplier partnerships to enhance our innovative portfolio and service offerings. Pharm-Rx’s strong team and industry expertise broadens our capabilities to help accelerate growth with nutrition and over-the-counter (OTC) pharmaceutical customers.
See More
Actylis partners with Novo Nordisk Pharmatech
Actylis and Novo Nordisk Pharmatech partner for the distribution of BKC in targeted European countries
Actylis partners with Novo Nordisk Pharmatech A/S for the distribution of pharmaceutical grade Benzalkonium Chloride (BKC) to the pharmaceutical and medical device markets in Germany, Spain, Portugal, UK and Ireland.
See More
Actylis, NCS South Africa, and Agni Chemicals Announce Tripartite Partnership
Actylis, NCS South Africa, and Agni Chemicals Announce Tripartite Partnership
Actylis has joined forces with NCS, a prominent South African polymer manufacturer with over 100 years in the paint and coatings industry, and Agni Chemicals, a creative entrepreneurial chemical supply chain company, to provide coating resins in North America from a new and reliable source outside of the APAC region.
See More
Actylis Expands WFI Manufacturing Capabilities in Canada
Actylis launched Water for Injection (WFI) and additional ISO Class 7 manufacturing space in Canada
Actylis today announced the launch of Water for Injection (WFI) and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada. Used for the preparation of media, buffers, and other aqueous solutions, Actylis’ WFI meets monographs for pharmacopoeias worldwide, and can be provided in both custom and standard packaging configurations.
See More
Actylis Achieves Silver EcoVadis Rating
Actylis Achieves Silver EcoVadis Rating, Demonstrating Commitment to Sustainability Excellence
Actylis is proud to announce its attainment of a Silver rating from EcoVadis, solidifying its position in the 85th percentile among industry peers. This remarkable achievement underscores Actylis' unwavering commitment to sustainable practices and its dedication to fostering a more responsible and eco-conscious future.
See More
Innovassynth and Actylis partner
Innovassynth and Actylis partner to address Nucleic Acid Supply Chain Vulnerabilities
A new partnership between Innovassynth and Actylis, two industry-leading companies offering choice and flexibility. This collaboration will allow Actylis to add Innovassynth’s portfolio of nucleosides to its range of critical raw materials.
See More
Actylis Partners with Norway-based Zooca
Zooca® and Actylis announce a strategic partnership
Zooca and Actylis have joined forces in a strategic partnership that will enable Zooca to expand its innovative products from zooplankton, sustainably harvested in the Norwegian Sea, across Europe through Actylis’ extensive network. This partnership will also allow Actylis to add this cutting-edge zooplankton oil to its nutrition product portfolio.
See More
Actylis opens innovative API manufacturing cGMP facility in Oregon, USA
Actylis opens a 30,000ft2 cGMP facility in Eugene, OR, USA to bolster our innovative API manufacturing capabilities.
The new facility focuses on the manufacture of innovative APIs and excipients at both clinical trial and full commercial scale. Our new state-of-the-art facility has 7 manufacturing suites and our clean rooms will be ISO Class 8 compliant by Q3. We have a number of different reactors to allow flexibility for a variety of chemistries.
See More
Expansion of distribution partnership in Europe
Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership
Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
See More
Actylis Invests in Manchester Manufacturing and R&D Site
$450k Investment in Actylis Manchester Facility Delivers Expanded Product & Service Offering
Actylis Invests in the Modernization and Expansion of Manchester Plant to Increase Manufacturing and R&D Capabilities.
See More
Announcing Actylis
Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse
Actylis Integrates Aceto and its 10 Acquired Specialists with Broad Expertise in GMP and non-GMP Raw Material Manufacturing and Sourcing into a Singular Global Brand. Unique Hybrid Model Provides Unparalleled Flexibility for Individualized, Customer-Centric Ingredient Solutions Along with Exceptional Supply Chain Dependability.
See More
Aceto Acquires Biotron
Aceto, the supplier of choice for life sciences and advanced technology specialty ingredients, today announced the acquisition of Biotron Laboratories and Talus Mineral Company (affiliated entities collectively referred to as Biotron herein), leading manufacturers of specialty ingredients for the nutritional supplements industry.
See More
Aceto Acquires A&C Bio Buffer
Aceto announced today the acquisition of Limerick, Ireland based A&C Bio Buffer, a GMP (Good Manufacturing Practices) manufacturer of custom buffer and chemical blend products used in the manufacturing of biopharmaceutical drug products
See More
Aceto Acquires Cascade Chemistry
Aceto announced today the acquisition of Eugene, Oregon-based Cascade Chemistry, manufacturer of active pharmaceutical ingredients (APIs), regulatory starting materials and advanced intermediates. With this acquisition, Aceto now provides customers enhanced support throughout the drug development process and greater access to expanded North American manufacturing, particularly for APIs and advanced intermediates.
See More
Aceto Acquires Finar Limited
May 17, 2021 - Aceto announced today the acquisition of a majority stake in Finar Limited. Finar is a leading manufacturer, supplier, and distributor of pharmaceutical excipients, lab chemicals, aquaculture inputs, and food grade additives. The acquisition complements Aceto’s growth strategy, enhancing and expanding the company’s manufacturing footprint, R&D capabilities, and quality expertise.
See More
Aceto Acquires A&C
Aceto Strengthens Self-Manufacturing and Vaccine and Biopharmaceutical Offering With Acquisition of A&C
Acquisition of A&C expands Aceto’s Western manufacturing footprint
See More
Expanded Bioreagent Portfolio
Aceto, a leading global virtual manufacturer of specialty materials for life sciences and advanced technology end markets, announced today the introduction of an expanded portfolio for biopharmaceutical and cell culture reagent manufacturers. This offering will be built on the established expertise of Pharma Waldhof, one of Aceto’s key facilities located in Düsseldorf, Germany, developing and commercializing active ingredients, key intermediates, excipients, and reagents for multiple life science industries including pharmaceuticals, diagnostics, cosmetics, and nutrition. The Biopharma and Cell Culture portfolio will leverage Pharma Waldhof’s worldwide manufacturing and distribution capabilities, tailor-made filling and packing, and experience as a major supplier to worldwide biopharma and cell biology industries.
See More
Aceto Acquires IsleChem
Aceto Establishes Chemical Manufacturing and R&D Capabilities in the US Through Acquisition of IsleChem
Acquisition enhances Aceto’s ability to support customers through all stages of product development
See More
Aceto overview by CEO Gilles Cottier
In this short video, CEO Gilles Cottier talks about Aceto, it's value to customers, how supply chain challenges are evolving for our industries, and Aceto's strategy moving forward.
See More
Aceto Names Gilles Cottier as Chief Executive Officer and Rakesh Sachdev as Chairman
Following New Mountain Capital's growth investment into Aceto, life sciences materials veterans going to lead Aceto in its next phase of growth.
Port Washington, NY (USA) - June 20, 2019 - Aceto, a leading virtual manufacturer engaged in the development, marketing and sale of specialty materials serving the life sciences, nutrition, agricultural and advanced technology end markets, announced the appointment of Gilles Cottier as Chief Executive Officer and Rakesh Sachdev as Chairman of the Board of Directors.